In the largest comparison of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors to date, a study of nearly 2.3 million patients starting the drugs as monotherapy ...

The Global Hypertension Report by the World Health Organization (WHO) revealed that 1.4 billion people were living with ...

A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...

"In our study, we found that patients taking ARBs were more likely to die from suicide than similar patients taking ACE inhibitors (ACEIs), with an odds ratio of 1.63. This means that for every 100 ...

Angiotensin II receptor blockers (ARBs) are medications that relax blood vessels, allowing blood to flow more freely, which lowers blood pressure. ARBs are used to treat hypertension (high blood ...

A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A controversial study suggesting COVID-19 may be more severe in some ...

Do ACE inhibitors or angiotensin II receptor blockers (ARBs) offer renal protection to patients with diabetes or renal disease?— Negeen Farmand, PA-C, Los Angeles When should a clinician stop an ACE ...

May 5 (UPI) --Certain high blood pressure medications have been linked with more serious illness from COVID-19, but they don't increase a person's risk for getting the disease, a new study published ...

The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...